The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Zaytsev Evgeny | Director | Grant(A) | 20K | — | $0 |
| Jun 25, 2026 | Hebbar Sudarshan | Chief Medical Officer | Grant(A) | 124K | $0.80 | $100K |
| Jun 25, 2026 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Grant(A) | 187K | $0.80 | $150K |
| Jun 25, 2026 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Grant(A) | 187K | $0.80 | $150K |
| Jun 25, 2026 | Middleton Fred A | Director, 10% Owner | Buy(P) | 249K | $0.80 | $200K |
| Jun 25, 2026 | Wilson Robert N | Director | Grant(A) | 1.2M | $0.80 | $950K |
| Oct 13, 2025 | Glicklich Alan | Director | Grant(A) | 937 | — | $0 |
| Sep 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 3K | $3.07 | $8K |
| Sep 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 3K | $2.68 | $9K |
| Sep 12, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $3.12 | $16K |
| Sep 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 2K | $3.15 | $7K |
| Aug 29, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 800 | $2.74 | $2K |
| Aug 28, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 9K | $2.86 | $26K |
| Aug 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 4K | $2.79 | $10K |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Option exercise(M) | 15K | $1.53 | $23K |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 2K | $2.72 | $5K |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Option exercise(M) | 15K | $1.53 | $23K |
| Aug 19, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy(P) | 10K | $2.82 | $27K |
| Aug 19, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 1K | $2.79 | $3K |
| Aug 15, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy(P) | 4K | $2.79 | $12K |
| Aug 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $2.90 | $15K |
| Aug 14, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy(P) | 2K | $2.59 | $4K |
| Jul 28, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy(P) | 1K | $3.96 | $4K |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Sell(S) | 1K | $3.65 | $4K |
| Jul 22, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 2K | $3.78 | $6K |
| Jul 21, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Buy(P) | 1K | $3.40 | $3K |
| Jul 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 2K | $3.37 | $5K |
| Jul 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 2K | $2.88 | $6K |
| Jul 18, 2025 | Wilson Robert N | Director | Buy(P) | 5K | $2.87 | $13K |
| Jul 14, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Buy(P) | 3K | $2.47 | $6K |
| Jul 14, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 7K | $2.43 | $16K |
| Jul 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $1.60 | $8K |
| Jul 1, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy(P) | 1K | $1.85 | $2K |
| Jun 26, 2025 | Bardin Stephen | Chief Financial Officer | Buy(P) | 2K | $1.50 | $3K |
| Jun 26, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $1.44 | $6K |
| Jun 24, 2025 | Middleton Fred A | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Middleton Fred A | Director, 10% Owner | Grant(A) | 7K | — | $0 |
| Jun 24, 2025 | Middleton Fred A | Director, 10% Owner | Grant(A) | 20K | — | $0 |
| Jun 24, 2025 | Middleton Fred A | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Wilson Robert N | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Wilson Robert N | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Wilson Robert N | Director | Grant(A) | 12K | — | $0 |
| Jun 24, 2025 | Wilson Robert N | Director | Grant(A) | 37K | — | $0 |
| Jun 24, 2025 | Shaw Allan | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Shaw Allan | Director | Grant(A) | 26K | — | $0 |
| Jun 24, 2025 | Shaw Allan | Director | Grant(A) | 9K | — | $0 |
| Jun 24, 2025 | Shaw Allan | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Glicklich Alan | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Glicklich Alan | Director | Grant(A) | 4K | — | $0 |
| Jun 24, 2025 | Glicklich Alan | Director | Grant(A) | 15K | — | $0 |
| Jun 24, 2025 | Glicklich Alan | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Guerard Frederic | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Guerard Frederic | Director | Grant(A) | 15K | — | $0 |
| Jun 24, 2025 | Guerard Frederic | Director | Grant(A) | 5K | — | $0 |
| Jun 24, 2025 | Guerard Frederic | Director | Grant(A) | 10K | — | $0 |
| Jun 24, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Grant(A) | 78K | — | $0 |
| Jun 24, 2025 | Dunn Michael J. | President and COO | Grant(A) | 47K | — | $0 |
| Jun 24, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Grant(A) | 73K | — | $0 |
| Jun 24, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Grant(A) | 47K | — | $0 |
| Jun 24, 2025 | Bardin Stephen | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Jun 24, 2025 | Hebbar Sudarshan | Chief Medical Officer | Grant(A) | 83K | — | $0 |
| Jun 11, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $1.85 | $9K |
| Jun 6, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $1.78 | $9K |
| Jun 5, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 5K | $1.70 | $9K |
| May 30, 2025 | Bardin Stephen | Chief Financial Officer | Buy(P) | 1K | $1.69 | $2K |
| Apr 23, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Grant(A) | 285K | — | $0 |
| Apr 23, 2025 | Hebbar Sudarshan | Chief Medical Officer | Grant(A) | 175K | — | $0 |
| Apr 23, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Grant(A) | 160K | — | $0 |
| Apr 23, 2025 | Dunn Michael J. | President and COO | Grant(A) | 125K | — | $0 |
| Apr 23, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Grant(A) | 125K | — | $0 |
| Apr 23, 2025 | Bardin Stephen | Chief Financial Officer | Grant(A) | 130K | — | $0 |
| Apr 5, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Grant(A) | 65K | — | $0 |
| Apr 5, 2025 | Hebbar Sudarshan | Chief Medical Officer | Grant(A) | 91K | — | $0 |
| Apr 5, 2025 | Dunn Michael J. | President and COO | Grant(A) | 65K | — | $0 |
| Apr 5, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Grant(A) | 83K | — | $0 |
| Apr 5, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Grant(A) | 148K | — | $0 |
| Apr 5, 2025 | Bardin Stephen | Chief Financial Officer | Grant(A) | 68K | — | $0 |
| Jan 15, 2025 | Glicklich Alan | Director | Grant(A) | 20K | — | $0 |
| Dec 6, 2024 | Middleton Fred A | Director, 10% Owner | Buy(P) | 5K | $2.65 | $13K |
| Nov 1, 2024 | Wilson Robert N | Director | Buy(P) | 53K | $3.75 | $200K |
| Nov 1, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Buy(P) | 53K | $3.75 | $200K |
| Nov 1, 2024 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Buy(P) | 20K | $3.75 | $75K |
| Nov 1, 2024 | Middleton Fred A | Director, 10% Owner | Buy(P) | 20K | $3.75 | $75K |
| Nov 1, 2024 | Middleton Fred A | Director, 10% Owner | Buy(P) | 87K | $3.75 | $326K |
| Nov 1, 2024 | Middleton Fred A | Director, 10% Owner | Buy(P) | 877 | $3.75 | $3K |
| Nov 1, 2024 | Sanderling Venture Partners VI LP | 10% Owner | Buy(P) | 877 | $3.75 | $3K |
| Nov 1, 2024 | Sanderling Venture Partners VI LP | 10% Owner | Buy(P) | 87K | $3.75 | $326K |
| Sep 9, 2024 | Dunn Michael J. | President and COO | Option exercise(M) | 12K | $1.39 | $16K |
| Sep 9, 2024 | Dunn Michael J. | President and COO | Option exercise(M) | 12K | — | — |
| Aug 27, 2024 | Shaw Allan | Director | Grant(A) | 10K | — | $0 |
| Aug 27, 2024 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Buy(P) | 1K | $4.19 | $4K |
| Aug 27, 2024 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER, Director, 10% Owner | Grant(A) | 115K | — | $0 |
| Aug 27, 2024 | Hebbar Sudarshan | Chief Medical Officer | Grant(A) | 83K | — | $0 |
| Aug 27, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER, Director, 10% Owner | Grant(A) | 78K | — | $0 |
| Aug 27, 2024 | Stauderman Kenneth A. | Chief Scientific Officer | Grant(A) | 63K | — | $0 |
| Aug 27, 2024 | Dunn Michael J. | President and COO | Grant(A) | 63K | — | $0 |
| Aug 27, 2024 | Wilson Robert N | Director | Grant(A) | 10K | — | $0 |
| Aug 27, 2024 | Middleton Fred A | Director, 10% Owner | Grant(A) | 10K | — | $0 |
| Aug 27, 2024 | Bjerkholt Eric | Director | Grant(A) | 10K | — | $0 |
| Aug 27, 2024 | Guerard Frederic | Director | Grant(A) | 10K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).